Spleen Tyrosine Kinase (SYK) negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy
A. J. Millan, V. Allain, I. Nayak, O. A. Aguilar, J. S. Arakawa- Hoyt, G. Ureno, A. G. Rothrock, A. Shemesh, J. Eyquem, J. Das, L. L. Lanier
This study shows that SYK negatively regulates NK cell signaling and that its deletion enhances CD19-CAR NK cell efficacy in cancer immunotherapy.
bioRxiv · Jul 9, 2024 · PreprintImmunology